FDA Approved: FOSAPREPITANT — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approves a generic version of fosaprepitant from Mylan Institutional LLC via an Original Application (ANDA) to prevent chemotherapy-induced nausea and vomit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

ORIG AP for FOSAPREPITANT (FOSAPREPITANT)